相关实验视频
Updated: Jun 21, 2025

Fixation and Operational Method for Abdominal Massage in T2DM Mice
Published on: March 7, 2025
甲福明与2型糖尿病患者的炎症性肠病结果改善有关:一种倾向匹配的队列研究
Jessica C Petrov1, Aakash A Desai1, Gursimran S Kochhar2
1Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
在患有炎症性肠病 (IBD) 和2型糖尿病 (T2DM) 的患者中,甲福明的使用与减少对静脉注射类固醇的需求有关,对于克罗恩病患者来说,手术的风险更低. 这些发现表明甲胺可能会改善IBD的结果.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲福明具有抗炎性质,影响氧化应激,肠道屏障功能和微生物群.
- 炎症性肠病 (IBD) 涵盖了胃肠道的慢性炎症状况.
- 2型糖尿病 (T2DM) 是一种以胰岛素抵抗为特征的代谢障碍.
研究的目的:
- 为了研究甲胺对IBD结局的影响,同时诊断为T2DM的患者.
- 为了比较T2DM患者的IBD相关事件,开始使用甲福明与其他降血糖药物.
主要方法:
- 使用TrinetX数据库进行回顾性队列研究.
- 纳入标准:患有IBD和T2DM的患者开始服用甲福林或控制药物 (口服低血糖药/胰岛素).
- 倾向性得分匹配用于创建可比较的队列;主要结果评估在启动后的1,2,3年.
主要成果:
- 这项研究包括1323名性结肠炎 (UC) 和1278名克罗恩病 (CD) 患者.
- 甲胺使用者在1,2,3年内对UC和CD显示需要静脉注射类固醇的可能性显著降低.
- 接受甲福明治疗的CD患者在1年和3年内有较低的IBD相关手术风险;UC患者没有观察到对手术风险的显著影响.
结论:
- 在IBD和T2DM患者中使用甲胺与改善的临床结果有关.
- 这些发现表明,在这种患者群体中,甲福明在治疗IBD方面具有潜在的治疗益处.
更多相关视频
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

